181 related articles for article (PubMed ID: 37973153)
21. Metabolism-Related Prognostic Biomarkers, Purine Metabolism and Anti-Tumor Immunity in Colon Adenocarcinoma.
Liu H; Zhang Y; Zhang Q; Zhang T; Lu T
Front Biosci (Landmark Ed); 2023 Dec; 28(12):328. PubMed ID: 38179743
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma.
Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F
Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216
[TBL] [Abstract][Full Text] [Related]
23. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
Front Oncol; 2022; 12():876660. PubMed ID: 35747790
[TBL] [Abstract][Full Text] [Related]
24. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma.
Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y
Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338
[TBL] [Abstract][Full Text] [Related]
25. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes.
Ren Y; He S; Feng S; Yang W
Front Public Health; 2022; 10():916364. PubMed ID: 35712285
[TBL] [Abstract][Full Text] [Related]
26. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
Front Oncol; 2022; 12():904464. PubMed ID: 35912258
[TBL] [Abstract][Full Text] [Related]
27. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
[No Abstract] [Full Text] [Related]
28. Development of a prognostic model for personalized prediction of colon adenocarcinoma (COAD) patient outcomes using methylation-driven genes.
Chen D; Zhang B; Kang K; Li L; Liao Y; Qing S; Di Y
J Appl Genet; 2023 Dec; 64(4):713-721. PubMed ID: 37589877
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma.
Miao YD; Kou ZY; Wang JT; Mi DH
World J Clin Cases; 2021 Oct; 9(29):8671-8693. PubMed ID: 34734046
[TBL] [Abstract][Full Text] [Related]
30. The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma.
Hu G; Li J; Zeng Y; Liu L; Yu Z; Qi X; Liu K; Yao H
Sci Rep; 2023 Aug; 13(1):13919. PubMed ID: 37626132
[TBL] [Abstract][Full Text] [Related]
31. Identification and validation of a prognostic risk-scoring model based on sphingolipid metabolism-associated cluster in colon adenocarcinoma.
Yuan Q; Zhang W; Shang W
Front Endocrinol (Lausanne); 2022; 13():1045167. PubMed ID: 36518255
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
33. Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma.
Guo Y; Liu N
J Oncol; 2022; 2022():5388283. PubMed ID: 36090899
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Characterization of RNA-Binding Proteins in Colon Adenocarcinoma Identifies a Novel Prognostic Signature for Predicting Clinical Outcomes and Immunotherapy Responses Based on Machine Learning.
Miao Y; Yuan Q; Wang C; Feng X; Ren J; Wang C
Comb Chem High Throughput Screen; 2023; 26(1):163-182. PubMed ID: 35379120
[TBL] [Abstract][Full Text] [Related]
35. MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method.
Li Z; Jiang L; Zhao R; Huang J; Yang W; Wen Z; Zhang B; Du G
Medicine (Baltimore); 2021 May; 100(21):e26068. PubMed ID: 34032736
[TBL] [Abstract][Full Text] [Related]
36. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
[TBL] [Abstract][Full Text] [Related]
37. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
38. Exploration of Potential Roles of m5C-Related Regulators in Colon Adenocarcinoma Prognosis.
Huang Y; Huang C; Jiang X; Yan Y; Zhuang K; Liu F; Li P; Wen Y
Front Genet; 2022; 13():816173. PubMed ID: 35281843
[No Abstract] [Full Text] [Related]
39. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674
[TBL] [Abstract][Full Text] [Related]
40. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma.
Gao H; Xing F
BMC Med Inform Decis Mak; 2022 Oct; 22(1):277. PubMed ID: 36273131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]